首页 | 本学科首页   官方微博 | 高级检索  
检索        

三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究
引用本文:谢玲,胡小军,訾璐,王玉,王青,周晶冰.三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究[J].世界中医药,2016(10).
作者姓名:谢玲  胡小军  訾璐  王玉  王青  周晶冰
作者单位:武汉市普仁医院中医科,武汉,430081
基金项目:武汉市临床医学科研项目(编号:WX12D15)
摘    要:目的:探讨三七降脂粉对高脂血症合并脂肪肝患者降血脂作用的影响研究。方法:选取武汉市普仁医院收治的高脂血症合并脂肪肝患者79例,采用随机数字表法将患者分为治疗组(40例)与对照组(39例),对照组患者采用辛伐他汀降血脂治疗,治疗组患者在对照组的基础上采用三七降脂粉治疗,比较2组患者临床疗效、血脂水平与超声检查征象的差异。结果:治疗组有效率明显高于对照组(P0.05)。治疗前,2组患者TC、TG、LDL-C、HDL-C水平比较差异无统计学意义(P0.05),治疗后,全部患者TC、TG、LDL-C水平明显低于治疗前(P0.05),HDL-C水平明显高于治疗前(P0.05),治疗组患者TC、TG、LDL-C水平明显低于对照组(P0.05),HDL-C水平明显高于对照组(P0.05)。治疗组肝脏正常/减小比例,肝脏回声衰减比例明显高于对照组(P0.05)。结论:三七降脂粉对高脂血症合并脂肪肝患者降血脂作用显著,且显著改善肝脏功能,值得临床推广应用。

关 键 词:三七降脂粉  高脂血症  脂肪肝  血脂
收稿时间:2016/1/7 0:00:00

Research on the Effect of Sanqi Jiangzhi Powder on Lowing Blood Liquid of Patients with Hyperlipidemia and Hepatic Steatosis
Xie Ling,Hu Xiaojun,Zi Lu,Wang Yu,Wang Qing,Zhou Jingbing.Research on the Effect of Sanqi Jiangzhi Powder on Lowing Blood Liquid of Patients with Hyperlipidemia and Hepatic Steatosis[J].World Chinese Medicine,2016(10).
Authors:Xie Ling  Hu Xiaojun  Zi Lu  Wang Yu  Wang Qing  Zhou Jingbing
Institution:Department of traditional Chinese Medicine, Puren Hospital, Wuhan 430081,China
Abstract:To study the effect of Sanqi Jiangzhi Powder on lowing blood liquid of patients with hyperlipidemia and hepatic steatosis.Methods: Seventy-nine cases of hyperlipidemia combined with fatty liver treated in the hospital were selected and divided into observation group (40 cases) and control group (39 cases) by random number table method. Patients in the control group were treated by simvastatin cholesterol-lowering treatment, while patients in the observation group were additionally given Sanqi Jiangzhi Powder. Differences of clinical effect, lipid levels and B ultrasonic examination signs between the two groups were compared. Results: The efficacy rate of the observation group was significantly higher than that of the control group with a statistically significant difference (P<0.05). There was no statistically significant difference in TC, TG, LDL, HDL-C levels of patients of the two groups before the treatment (P>0.05), while TC, TG, LDL-C levels of all patients were significantly lower after treatment (P<0.05). HDL-C level was significantly higher (P<0.05) and TC, TG and LDL-C levels of the observation group were significantly lower than those of the control group (P<0.05). HDL-C level was significantly higher than that of the control group (P<0.05). The liver normal /reduced proportion and liver echo attenuation proportion of the observation group were significantly higher than those of the control group (P<0.05). Conclusion: Sanqi Jiangzhi Powder has significant effect of lowing blood liquid for patients with hyperlipidemia and fatty liver and significantly improve liver function, which is worthy of clinical popularization and application.
Keywords:Sanqi Jiangzhi Powder  Hyperlipidemia  Fatty liver  Lipid
本文献已被 CNKI 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号